Q1 2022 Holdings
Filed 2022-05-16 | 70 holdings | $521.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $162.7M | 515,943 | 31.2% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $105.2M | 1,836,050 | 20.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $69.7M | 2,046,269 | 13.4% |
| Absci Corporation(ABSI) | COM | 00091E109 | $67.7M | 8,031,094 | 13.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $54.6M | 648,837 | 10.5% |
| Bioventus Inc(BVS) | COM CL A | 09075A108 | $18.3M | 1,296,739 | 3.5% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $13.1M | 772,397 | 2.5% |
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $8.8M | 1,920,960 | 1.7% |
| Annexon Inc(ANNX) | COM | 03589W102 | $8.7M | 3,202,917 | 1.7% |
| Alpha Teknova Inc(TKNO) | COM | 02080L102 | $7.8M | 567,800 | 1.5% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.4M | 696,377 | 0.3% |
| Cytosorbents Corp(CTSO) | COM NEW | 23283X206 | $850.0K | 266,365 | 0.2% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $502.4K | 12,957,222 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $211.5K | 22,329,386 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $161.2K | 1,970,511 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $120.8K | 1,815,698 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $110.7K | 2,615,030 | 0.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $109.2K | 7,432,429 | 0.0% |
| Science 37 Holdings Inc | COM | 808644108 | $106.0K | 19,808,234 | 0.0% |
| The Beauty Health Company(SKIN) | COM CL A | 88331L108 | $89.5K | 5,304,505 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $89.1K | 3,334,355 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $65.6K | 1,976,923 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $63.6K | 441,274 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $62.7K | 3,691,312 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $58.0K | 6,245,911 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $43.9K | 9,217,945 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $42.6K | 2,024,368 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $42.3K | 3,018,784 | 0.0% |
| Augmedix Inc(AUGX) | COM | 05105P107 | $42.3K | 14,380,327 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $41.9K | 1,835,328 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $40.9K | 83,162 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $38.9K | 2,732,996 | 0.0% |
| 1Life Healthcare Inc | COM | 68269G107 | $37.7K | 3,404,835 | 0.0% |
| OAK STR Health Inc(OSH3EUR) | COM | 67181A107 | $32.4K | 1,203,619 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $31.5K | 271,218 | 0.0% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $31.3K | 3,906,770 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $31.0K | 2,407,326 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $30.3K | 3,805,403 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $29.7K | 411,017 | 0.0% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $28.3K | 6,871,738 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $27.3K | 53,445 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $26.9K | 736,175 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $25.0K | 1,485,800 | 0.0% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $23.9K | 5,619,914 | 0.0% |
| Stevanato Group S P A(STVN) | ORD SHS | T9224W109 | $23.1K | 1,150,225 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $22.7K | 1,602,285 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $21.6K | 3,080,801 | 0.0% |
| ICU MED Inc(ICUI) | COM | 44930G107 | $21.6K | 96,869 | 0.0% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $18.4K | 1,954,419 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $18.3K | 3,471,709 | 0.0% |